Sort
23,748 grants matching “melanoma”
Localizing Immunotherapy to Improve Therapeutic Index
$395,388Karl D Wittrup · Massachusetts Institute Of Technology · R01 · FY2016 · CA
Vaccination with IL-15 DC to Generate Melanoma-specific Protective Memory T Cells
$395,213Anna Karolina Palucka · Baylor Research Institute · R01 · FY2012 · CA
Activation and Regulation of the Understudied Kinome Using MIB/MS Technology
$395,126Gary L. Johnson · Univ Of North Carolina Chapel Hill · U01 · FY2016 · MH
Activation and Regulation of the Understudied Kinome Using MIB/MS Technology
$395,126Gary L. Johnson · Univ Of North Carolina Chapel Hill · U01 · FY2015 · MH
Targeting lymph node metastases to prevent cancer progression
$395,043Timothy P Padera · Massachusetts General Hospital · R01 · FY2017 · CA
Dendritic Cell Vaccines to Elicit Polyspecific ThI type Anti- Tumor Immunity
$395,038Louis D Falo · University Of Pittsburgh At Pittsburgh · P01 · FY2007 · CA
Platelets-Mediated Delivery of Checkpoint Inhibitors for Post-Surgical Cancer Immunotherapy
$394,916Song Li · University Of California Los Angeles · R01 · FY2022 · CA
Platelets-Mediated Delivery of Checkpoint Inhibitors for Post-Surgical Cancer Immunotherapy
$394,916Song Li · University Of California Los Angeles · R01 · FY2023 · CA
A Tailored Internet Intervention for Skin Cancer Risk Reduction in Young Adults
$394,884Carolyn J. Heckman · Fox Chase Cancer Center · R01 · FY2011 · CA
MELANOMA VACCINE FOR HELPER T CELLS COMBINED WITH TARGETED OR IMMUNE THERAPIES
$394,792Craig Lee Slingluff · University Of Virginia · R01 · FY2016 · CA
MELANOMA VACCINE FOR HELPER T CELLS COMBINED WITH TARGETED OR IMMUNE THERAPIES
$394,792Craig Lee Slingluff · University Of Virginia · R01 · FY2015 · CA
MELANOMA VACCINE FOR HELPER T CELLS COMBINED WITH TARGETED OR IMMUNE THERAPIES
$394,792Craig Lee Slingluff · University Of Virginia · R01 · FY2017 · CA
Combinational Immunotherapy Targeting the Melanoma-Associated Vasculature
$394,575Walter J Storkus · University Of Pittsburgh At Pittsburgh · R01 · FY2013 · CA
Define the role of POT1 mutations in genome instability and cancer
$394,567Agnel Sfeir · New York University School Of Medicine · U01 · FY2019 · CA
Targeting Vulnerabilities Exposed by Cancer Treatment-Induced Lineage Plasticity
$394,548Peter S Nelson · Fred Hutchinson Cancer Center · R01 · FY2023 · CA
Modeling to Minimize Detection Bias in Cancer Risk Prediction Studies
$394,532Ruth D Etzioni · Fred Hutchinson Cancer Research Center · R01 · FY2020 · CA
Targeting Lag-3 and PD -1 in Myeloid Cells of GBM
$394,429Michael Lim · Stanford University · R01 · FY2025 · NS
Developmental origins of cancer
$394,362Sridhar Hannenhalli · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Induction of cytotoxic T cells by pulmonary dendritic cells
$394,355Claudia V Jakubzick · National Jewish Health · R01 · FY2014 · HL
Project 3: Inhibiting Oxidative Phosphorylation in Pancreatic Cancer
$394,322Gauri Varadhachary · University Of Tx Md Anderson Can Ctr · P50 · FY2019 · CA
Engineering Nanomaterials to Prime Immunity
$394,303James J. Moon · University Of Michigan At Ann Arbor · R01 · FY2018 · CA
Functional Analysis of the BAP1 Metastasis Suppressor Gene in Uveal Melanoma
$394,250Frank J. Rauscher · Wistar Institute · R01 · FY2016 · CA
Promotion of tumor invasion and pseudosenescence by the aging microenvironment
$394,250Ashani T Weeraratna · Wistar Institute · R01 · FY2017 · CA
Promotion of tumor invasion and pseudosenescence by the aging microenvironment
$394,250Ashani T Weeraratna · Wistar Institute · R01 · FY2018 · CA
Promotion of tumor invasion and pseudosenescence by the aging microenvironment
$394,250Ashani T Weeraratna · Wistar Institute · R01 · FY2016 · CA